<p>Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017</p>
Lists
Only you see this
Abstract
Colistin was a last resort antibiotics for empirical CR-Enterobacterales treatments, since especially the percentage of CR-<i>K. pneumoniae</i> was 30.0% of all IAI, UTI and RTI isolates, with an incidence of 24.8% CR strains, of which 88.6% were susceptible to colistin. Also other analyzed CR-Enterobacterales showed colistin susceptibilities of ≥80.0%. However, resistance rates of IAI derived CR-<i>K. pneumoniae</i> and CR-<i>E. coli</i>, and CR-<i>K. pneumoniae</i> UTI isolates to colistin increased between 2015 and 2017, which should further be closely monitored.
BibTeX
@inproceedings{zhang2020lt,
author = {Hui Zhang and Jingjia Zhang and Yue Kang and Qiwen Yang and Yingchun Xu},
title = {{\<p\>Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017\</p\>}},
booktitle = {Infection},
year = {2020},
doi = {10.2147/idr.s250384},
}Loading related content...